But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers to ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Diabetic shock can occur when blood sugar levels get dangerously low or high. Learn how to identify symptoms and get to ...

Medical device manufacturer Medtronic (MDT) plans to separate its diabetes business into a stand-alone company, ...